4.4 Article

Signaling Mechanisms Mediating Uridine Adenosine Tetraphosphate-induced Proliferation of Human Vascular Smooth Muscle Cells

Journal

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
Volume 58, Issue 6, Pages 654-662

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FJC.0b013e318231e929

Keywords

extracellular nucleotides; smooth muscle cell proliferation; uridine adenosine tetraphosphate; p70 S6 kinase; mitogen-activated protein kinase

Funding

  1. Heart and Stroke Foundation of Alberta
  2. University of Calgary
  3. Alberta Heritage Foundation for Medical Research (AHFMR)
  4. Canada Research Chair (Tier 1) in Vascular Smooth Muscle Research

Ask authors/readers for more resources

Proliferation of vascular smooth muscle cells (SMCs) plays an important role in the development of atherosclerosis and restenosis. Extracellular mononucleotides, such as adenosine triphosphate and uridine-5'-triphosphate stimulate SMC proliferation. However, the effects of dinucleotides on SMC proliferation and their underlying signaling mechanisms are less well defined. Recently, increasing evidence suggests that the dinucleotide, uridine adenosine tetraphosphate (Up(4)A) plays a role in the regulation of cardiovascular function. We have previously demonstrated that Up(4)A stimulates DNA synthesis and proliferation of human SMCs. This study investigated the signaling mechanisms underlying the proliferative effect of Up(4)A. Up(4)A-induced increase in bromodeoxyuridine incorporation was blocked by the mammalian target of rapamycin inhibitor, rapamycin, and the MEK inhibitor, PD98059. Up(4)A-stimulated phosphorylation and kinase activity of S6 kinase (S6K) and Erk1/2 were inhibited by PD98059, whereas phosphorylation and kinase activity of S6K, but not Erk1/2, were inhibited by rapamycin. Up(4)A also increased the phosphorylation of Akt, which was blocked by the PI3-kinase inhibitor, LY294002. Up(4)A-stimulated activation of S6K, but not Erk1/2, was also prevented by LY294002. Furthermore, Up(4)A-stimulated phosphorylation and kinase activity of S6K and Erk1/2 were inhibited by the P2 receptor antagonist, suramin, but not by the P2X receptor antagonist, Ip(5)I. Up(4)A also stimulated an increase in the protein expression of cycle-dependent kinase 2, which was prevented by rapamycin, PD98059, and suramin. These results suggest that the signaling mechanisms underlying the Up(4)A-stimulated proliferation of SMCs are mediated by P2Y receptors and involve the PI3-K/Akt and mitogen-activated protein kinase pathways, leading to the independent activation of S6K and an increase in cycle-dependent kinase 2 expression. This work stresses the concept that dinucleotides, like mononucleotides, play potentially important roles in the regulation of vascular function.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available